Travere Therapeutics
TVTX
TVTX
168 hedge funds and large institutions have $1.27B invested in Travere Therapeutics in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 83 increasing their positions, 41 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less capital invested
Capital invested by funds: $1.9B → $1.27B (-$627M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
81% less call options, than puts
Call options by funds: $1.9M | Put options by funds: $9.74M
Holders
168
Holding in Top 10
3
Calls
$1.9M
Puts
$9.74M
Top Buyers
| 1 | +$27.4M | |
| 2 | +$21M | |
| 3 | +$18.8M | |
| 4 |
BlackRock
New York
|
+$16.4M |
| 5 |
Walleye Capital
New York
|
+$10.6M |
Top Sellers
| 1 | -$92.5M | |
| 2 | -$28.4M | |
| 3 | -$22.2M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$14.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$13.5M |